Chinese Journal of Hepatology 2007 Issue 3 Stem cells and liver diseases

..............page:219-220

xiao xi

..............page:173

..............page:208

CD4+CD25+Treg cell and its function in liver diseases: a review
ZHENG Ming-hua;ZHANG You-cai;CHEN Yong-ping

..............page:238-240

Transcatheter hepatic arterial chemoembolization followed by three-dimentional conformal radiotherapy for the treatment of primary hepatic cancer with portal vein tumor thrombus
XIA Xing-zhou;MA Ying-guang;LIU Wei

..............page:236-237

The repopulation of human L02 hepatocytes in tolerant rats treated with retrorsine
LIN Hu;MAO Qing;WANG Yu-ming;JIANG Ye-gui;JIANG Li

..............page:234-235

Detection of hepatitis B virus cccDNA in liver tissues of patients with hepatocellular carcinoma
ZHANG Tao;HAN Tao;GAO Ying-tang;CHEN Hao;DU Zhi;WANG Yi-jun

..............page:232-233

A 72 week follow-up study of chronic hepatitis C patients treated with peginterferon alfa-2b and ribavirin
YU Shu-Li;ZHANG Zhao-hua;LU Hui;ZHANG Qin-gang;WANG Yao-zong

..............page:231

Changes of liver fibrosis markers in nonalcoholic fatty liver disease patients
HONG Xiao-fei;YU Chao-hui;LI You-ming

..............page:229-230

A study of the association between PPAR γ 2 gene Pro12Ala polymorphism and NAFLD
YE Qing;L(U) Zong-shun

..............page:228-229

A study on the role of cyclooxygenase-2 in lipopolysaccharide mediated fulminate hepatic failure
SHI Bai-nian;LIU Jiang;HE Jian-fang;DAI Li-cheng;ZHOU Jian-fang;ZHAO Wei-feng;GAN Jian-he

..............page:226-227

Reversal of adriamycin resistance of hepatocellular carcinoma by targeting it with recombined adenovirus carrying antisense multidrug resistance gene 1 RNA
MEI Ying;SHI Yu-jun;DING Xiong;WU Chuan-xin;JIAN Hua-gang;GONG Jian-ping;LIU Chang-an

..............page:199-203

Construction and identification of matrix metalloproteinal inhibitor-1 siXNA eukaryotic expression vectors
TIAN Li;LI Ji-chang;ZHAO Guo-qiang;CHEN Kui-sheng;FAN Wen-hui;LOU Xin;SUN Miao-miao;CAO Xue-quan

..............page:196-198

Effects of pioglitazone on the morphology and the expression of connective tissue growth factor of transforming growth factor beta-induced rat hepatic stellate cells in vitro
JIA Jin-bin;LIU Yan;CHEN Wei-hua;LIU Mei;LU Lun-gen

..............page:192-195

Genetic polymorphisms of MxA protein and eIF-2α-reg2 and their responses to interferon treatment in patients with chronic hepatitis B
HUANG Yan-xiang;MA Li-na;CHEN Xin-yue;LI Zhuo;HUANG Yun-li;SHEN Cheng-li;MA Bing

..............page:187-191

Changes of peripheral plasmacytoid dendritic cells and lymphocyte subsets in chronic hepatitis B patients treated with consensus interferon alpha
ZHANG Ai-min;WANG Hui-fen;JI Wei;ZHANG Zheng;YAN Tao;ZHANG Hui;WANG Fu-sheng

..............page:184-186

The relationship between the genotype of hepatitis B virus and clinical and liver pathological features of infected patients in the Zhoushan Islands, China
LI Shi-bo;LIN Zhi-yi;DING Xian-jun;LI Yi-wei;LI Shao-zuo;LI Chun-sheng;GU Ruo-wei;GUO Wei-li;ZHI Ri-zeng;DU Wen-jie

..............page:179-183

Human bone marrow derived multipotent adult progenitor cells differentiating into hepatocyte-like cells after being induced by co-culturing with human hepatocyte line L02
MU Ning;WANG Ming-yuan;LIN Yu-dong;GAO Yi

..............page:174-178

Tracing magnetically labeled mesenchymal stem cells transplanted into rat livers by MRI
CAI Jin-hua;FENG Gan-sheng;WANG Xin;LIU Guan-xin;ZHANG De-ying;HU Lin-yan

..............page:170-173

Human fetal liver nonparenchymal mesenchymal stem cells differentiate into functional hepatocyte-like cells in vitro
HE Nian-hai;ZHAO Wen-li;WANG Yu-ming

..............page:164-169

Stem cells for treating liver diseases: the current situation and possibilities in the near future
WEI Lai

..............page:161-163

A clinical study of thymosin alphal as an auxiliary in treating spontaneous peritonitis in patients with liver cirrhosis
MA Li-na;CHEN Xin-yue;CHEN Jie;HUANG Yun-li;SHEN Cheng-li

..............page:225

Overexpression of HCCR in hepatocellular carcinoma cells and its clinical significance
YANG Yang;ZHANG Guo-xin;SHI Rui-hua;LIN Yan;HAO Bo;WANG Xiao-yong;WANG Hong-di;HUANG Zu-hu

..............page:223-224

A study of liver cell transformation from bone marrow hematopoietic stem cells
ZHU Wei;QIU De-kai;LAI Zhuo-sheng;WANG Ya-dong;ZHANG Ya-li

..............page:221-222

The advancement and expectations in using hepatocytes in bioartificial livers
HUANG Jian-rong

..............page:217-218

Gene therapy of hepatic stem cells in treating liver diseases
YOU Hong

..............page:216-217

Clinical and pathological analysis of 100 cases of drug-induced liver injury
ZHOU Guang-de;ZHAO Jing-min;ZHANG Ling-xia;SUN Yan-ling;PAN Deng;YANG Jian-fa;ZHAO Yu-lai

..............page:212-215

The protective role of adiponectin in Con A-induced mouse liver injury
WANG Hui-zhong;LIN Hu;GAO De-lu;ZHAN Lin-sheng;WANG Quan-li

..............page:209-211

A study on the preventive effect of Lycium barbarum polysaccharide on the development of alcoholic fatty liver in rats and its possible mechanisms
GU Sai;WANG Pi-long;JIANG Rong

..............page:204-208